Healio (3/28, Downey) reports, “Older patients taking psychotropic medication were about three times more likely to develop dementia following a SARS-CoV-2 infection,” investigators concluded in a study that “assessed electronic health records of 1,755 adults aged 65 years and older to determine the one-year incidence rate of post-COVID-19 dementia, as well as the association between that and psychotropic medication use.” The study team evaluated “antipsychotics, antidepressants, benzodiazepines for stress and anxiety, mood stabilizers, anticonvulsants and anti-Parkinson disease medications.” The findings were published online March 18 in the journal Frontiers in Medicine. (SOURCE: APA Headlines)